FDA Approves Posterior Fixation System for Minimally Invasive Spine Surgery
- Home
- Public Policy
- FDA Approves Posterior Fixation System for Minimally Invasive Spine Surgery
- Categories
- Tags
FDA Approves Posterior Fixation System for Minimally Invasive Spine Surgery
On August 24, 2022, a notice was posted that Surgalign’s Cortera spinal fixation system received FDA 510(k) clearance.
Cortera is Surgalign’s new flagship posterior fixation system and has open and minimally invasive modules, according to a company news release. It will be integrated with Surgalign’s Holo Portal surgical system, and more implants and instruments are planned for the system in the next three to four years.
The device was developed from inception to clearance in about 16 months, according to Surgalign.
To read the press release see here: https://www.globenewswire.com/news-release/2022/08/24/2503786/0/en/Surgalign-Announces-FDA-510-k-Clearance-of-the-Cortera-Spinal-Fixation-System-The-Company-s-New-Flagship-Posterior-Fixation-Platform.html